account_num,net_change,tag,tag_depth,cik
825,15200000.0,GoodwillAndIntangibleAssetImpairment,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2710,-360800000.0,DeferredRevenueCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1025,160600000.0,AmortizationOfIntangibleAssets,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
845,160600000.0,AmortizationOfDeferredCharges,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
802,15200000.0,AssetImpairmentCharges,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
868,3954200000.0,AssetsCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
677,700200000.0,PrepaidExpenseCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
260,461100000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
455,461100000.0,InventoryNet,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
320,1957000000.0,ReceivablesNetCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
207,1957000000.0,AccountsNotesAndLoansReceivableNetCurrent,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
229,1957000000.0,AccountsReceivableNetCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
577,727900000.0,CashCashEquivalentsAndShortTermInvestments,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
645,727900000.0,CashAndCashEquivalentsAtCarryingValue,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1368,2820500000.0,PropertyPlantAndEquipmentNet,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
1711,6331900000.0,Goodwill,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1827,9607500000.0,IntangibleAssetsNetIncludingGoodwill,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3809,-208800000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3733,-4700000.0,AdditionalPaidInCapitalCommonStock,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2552,-689700000.0,AccruedLiabilitiesCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1848,39500000.0,LongTermInvestmentsAndReceivablesNet,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1626,39500000.0,LongTermInvestments,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
144,6584800000.0,CostOfRevenue,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1557,39500000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,920148_LABORATORY CORP OF AMERICA HOLDINGS
2590,-585100000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1732,3275600000.0,IntangibleAssetsNetExcludingGoodwill,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1077,-586000000.0,ProfitLoss,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1820,-547200000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2399,168800000.0,IncomeTaxExpenseBenefit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
819,18200000.0,DeferredIncomeTaxExpenseBenefit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2903,-585100000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2257,-1026000000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
456,160600000.0,DepreciationAndAmortization,4,920148_LABORATORY CORP OF AMERICA HOLDINGS
2004,-2700000.0,OtherNonoperatingIncomeExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
581,175800000.0,OperatingCostsAndExpenses,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1914,-38800000.0,IncomeLossFromDiscontinuedOperationsNetOfTax,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1133,15200000.0,RestructuringSettlementAndImpairmentProvisions,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2431,900000.0,NetIncomeLossAttributableToNoncontrollingInterest,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1478,-1500000.0,IncomeLossFromEquityMethodInvestments,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2149,-1024500000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1912,-585100000.0,NetIncomeLoss,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1709,150800000.0,InterestExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2041,456600000.0,OtherAssetsNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2091,12924100000.0,AssetsNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2089,16886000000.0,Assets,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2398,-690600000.0,AccountsPayableCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2347,-1380300000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2809,-6400000.0,FinanceLeaseLiabilityCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
2737,-6400000.0,LongTermDebtAndCapitalLeaseObligationsCurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
1854,150800000.0,InterestAndDebtExpense,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
2638,-6400000.0,DebtCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3154,-2900800000.0,LiabilitiesCurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3308,-4427600000.0,LongTermDebtNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3378,-80200000.0,FinanceLeaseLiabilityNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3303,-4507800000.0,LongTermDebtAndCapitalLeaseObligations,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3379,-662400000.0,OperatingLeaseLiabilityNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3796,-1085400000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3494,-423000000.0,OtherLiabilitiesNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3465,-8993500000.0,Liabilities,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
601,1488500000.0,SellingGeneralAndAdministrativeExpense,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
3645,-5593200000.0,LiabilitiesNoncurrent,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
1112,1664300000.0,OperatingExpenses,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1264,-848400000.0,OperatingIncomeLoss,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1665,-22600000.0,InvestmentIncomeNet,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
232,-2543500000.0,GrossProfit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
2130,-25300000.0,NonoperatingIncomeExpense,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
1205,-22600000.0,InvestmentIncomeNonoperating,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3917,-16886000000.0,LiabilitiesAndStockholdersEquity,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3260,-7873100000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,920148_LABORATORY CORP OF AMERICA HOLDINGS
3316,-7873100000.0,StockholdersEquity,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3834,-8069500000.0,RetainedEarningsAccumulatedDeficit,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3750,-4700000.0,AdditionalPaidInCapital,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
3661,-7700000.0,CommonStockValue,3,920148_LABORATORY CORP OF AMERICA HOLDINGS
173,-9128300000.0,Revenues,1,920148_LABORATORY CORP OF AMERICA HOLDINGS
